TP53 and neoplasm: Additionally, dysplasia is known to exhibit TP53 genetic abnormalities at an early stage of tumor development, making abnormal p53 protein expression a crucial immunohistochemical marker for distinguishing dysplasia from reactive atypia and sporadic adenomas.